Brinker International, Inc.
EAT · NYSE · Consumer Discretionary
$1.34 today
- Mkt cap $8.27B
- P/E 18.8
- Day $235.10 – $239.45
Confidence
High conviction
The read
Brinker’s EPS was in line at $3.07 as shares eased 0.56%, leaving fiscal 2027 execution as the key catalyst.
Brinker reported $3.07 EPS for the quarter ended June 30, exactly matching consensus. Shares closed at $237.27 on August 14, down 0.56%; guidance specifics were not provided, while management’s forward focus remained fiscal 2027 execution and Chili’s demand.
Confidence note: Reported EPS and price data were available, but specific guidance figures and event-day reaction data were unavailable.
What happened
Earnings print
Guidance
Price reaction
Street narrative
So what
What changed
What the market is pricing
Fundamental takeaway
Next 30–90 days
Chili’s demand translates into the expected profit growth, supporting the existing growth thesis and the 16.1% next-year EPS-growth expectation.
- Fiscal 2027 execution updates explicitly support the 16.1% next-year EPS-growth expectation.
- Chili’s sales strength is accompanied by improved profit delivery rather than demand-only commentary.
The in-line $3.07 EPS print and modest 0.56% decline leave the thesis intact, but valuation and execution remain balanced.
- Fiscal 2027 updates maintain the current execution narrative without a reduction in expected EPS growth.
- The share price remains above the 20-day SMA of $210.96 while execution information develops.
Demand fails to convert into profit growth, causing investors to reassess a stock up 73.42% over three months and carrying 4.31 debt-to-equity.
- Fiscal 2027 execution updates identify weaker profit growth or pressure on the 10.04% next-year EPS-growth expectation.
- Chili’s sales strength is explicitly disconnected from earnings delivery.
What to do
If you hold it
If you're watching
Add to Watchlist
- Fiscal 2027 execution updates, the named forward catalyst.
- Chili’s ability to convert demand strength into profit growth.
- Next-year EPS-growth expectations of 10.04% in quick statistics and 16.1% in growth metrics.
- Price relative to the $210.96 20-day SMA after the 0.56% post-print decline.